Cargando…
Diagnostic Accuracy of the Biosynex CryptoPS Cryptococcal Antigen Semiquantitative Lateral Flow Assay in Patients with Advanced HIV Disease
High cryptococcal antigen (CrAg) titers in blood are associated with subclinical meningitis and mortality in CrAg-positive individuals with advanced HIV disease (AHD). We evaluated a novel semiquantitative lateral flow assay (LFA), CryptoPS, that may be able to identify individuals with high CrAg ti...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7771453/ https://www.ncbi.nlm.nih.gov/pubmed/33087436 http://dx.doi.org/10.1128/JCM.02307-20 |
_version_ | 1783629689840992256 |
---|---|
author | Tenforde, Mark W. Boyer-Chammard, Timothée Muthoga, Charles Tawe, Leabaneng Milton, Thandi Rulaganyang, Ikanyeng Lechiile, Kwana Rukasha, Ivy Leeme, Tshepo B. Govender, Nelesh P. Ngidi, Julia Mine, Madisa Molloy, Síle F. Harrison, Thomas S. Lortholary, Olivier Jarvis, Joseph N. |
author_facet | Tenforde, Mark W. Boyer-Chammard, Timothée Muthoga, Charles Tawe, Leabaneng Milton, Thandi Rulaganyang, Ikanyeng Lechiile, Kwana Rukasha, Ivy Leeme, Tshepo B. Govender, Nelesh P. Ngidi, Julia Mine, Madisa Molloy, Síle F. Harrison, Thomas S. Lortholary, Olivier Jarvis, Joseph N. |
author_sort | Tenforde, Mark W. |
collection | PubMed |
description | High cryptococcal antigen (CrAg) titers in blood are associated with subclinical meningitis and mortality in CrAg-positive individuals with advanced HIV disease (AHD). We evaluated a novel semiquantitative lateral flow assay (LFA), CryptoPS, that may be able to identify individuals with high CrAg titers in a cohort of AHD patients undergoing CrAg screening. In a prospective cohort of patients with AHD (CD4 cell count, ≤200/μl) receiving CD4 count testing, whole blood was tested for CrAg by CryptoPS and the IMMY LFA; the two assays were conducted by two different operators, each blind to the results of the other assay. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of CryptoPS were assessed against the IMMY LFA as a reference. CryptoPS low-titer (T1 band) and high-titer (T2 band) results were compared with IMMY LFA titers obtained through serial dilution. A total of 916 specimens were tested. The sensitivity of the CryptoPS assay was 61.0% (25/41) (95% confidence interval [95% CI], 44.5 to 75.8%), its specificity was 96.6% (845/875) (95% CI, 95.1 to 97.7%), its PPV was 45.5% (95% CI, 32.0 to 59.4%), and its NPV was 98.1% (95% CI, 97.0 to 98.9%). All (16/16) CryptoPS false-negative results were obtained for samples with IMMY titers of ≤1:160. Of 29 patients (30 specimens) who tested positive by CryptoPS but negative by the IMMY LFA, none developed cryptococcal meningitis over 3 months of follow-up without fluconazole. Median CrAg titers were 1:20 (interquartile range [IQR], 0 to 1:160) in CryptoPS T1-positive samples and 1:2,560 (IQR, 1:1,280 to 1:10,240) in T2-positive samples. We conclude that the diagnostic accuracy of the CryptoPS assay was suboptimal in the context of CrAg screening, with poor sensitivity at low CrAg titers. However, the CryptoPS assay reliably detected individuals with high titers, which are associated with poor outcomes. |
format | Online Article Text |
id | pubmed-7771453 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | American Society for Microbiology |
record_format | MEDLINE/PubMed |
spelling | pubmed-77714532021-06-17 Diagnostic Accuracy of the Biosynex CryptoPS Cryptococcal Antigen Semiquantitative Lateral Flow Assay in Patients with Advanced HIV Disease Tenforde, Mark W. Boyer-Chammard, Timothée Muthoga, Charles Tawe, Leabaneng Milton, Thandi Rulaganyang, Ikanyeng Lechiile, Kwana Rukasha, Ivy Leeme, Tshepo B. Govender, Nelesh P. Ngidi, Julia Mine, Madisa Molloy, Síle F. Harrison, Thomas S. Lortholary, Olivier Jarvis, Joseph N. J Clin Microbiol Mycology High cryptococcal antigen (CrAg) titers in blood are associated with subclinical meningitis and mortality in CrAg-positive individuals with advanced HIV disease (AHD). We evaluated a novel semiquantitative lateral flow assay (LFA), CryptoPS, that may be able to identify individuals with high CrAg titers in a cohort of AHD patients undergoing CrAg screening. In a prospective cohort of patients with AHD (CD4 cell count, ≤200/μl) receiving CD4 count testing, whole blood was tested for CrAg by CryptoPS and the IMMY LFA; the two assays were conducted by two different operators, each blind to the results of the other assay. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of CryptoPS were assessed against the IMMY LFA as a reference. CryptoPS low-titer (T1 band) and high-titer (T2 band) results were compared with IMMY LFA titers obtained through serial dilution. A total of 916 specimens were tested. The sensitivity of the CryptoPS assay was 61.0% (25/41) (95% confidence interval [95% CI], 44.5 to 75.8%), its specificity was 96.6% (845/875) (95% CI, 95.1 to 97.7%), its PPV was 45.5% (95% CI, 32.0 to 59.4%), and its NPV was 98.1% (95% CI, 97.0 to 98.9%). All (16/16) CryptoPS false-negative results were obtained for samples with IMMY titers of ≤1:160. Of 29 patients (30 specimens) who tested positive by CryptoPS but negative by the IMMY LFA, none developed cryptococcal meningitis over 3 months of follow-up without fluconazole. Median CrAg titers were 1:20 (interquartile range [IQR], 0 to 1:160) in CryptoPS T1-positive samples and 1:2,560 (IQR, 1:1,280 to 1:10,240) in T2-positive samples. We conclude that the diagnostic accuracy of the CryptoPS assay was suboptimal in the context of CrAg screening, with poor sensitivity at low CrAg titers. However, the CryptoPS assay reliably detected individuals with high titers, which are associated with poor outcomes. American Society for Microbiology 2020-12-17 /pmc/articles/PMC7771453/ /pubmed/33087436 http://dx.doi.org/10.1128/JCM.02307-20 Text en Copyright © 2020 Tenforde et al. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Mycology Tenforde, Mark W. Boyer-Chammard, Timothée Muthoga, Charles Tawe, Leabaneng Milton, Thandi Rulaganyang, Ikanyeng Lechiile, Kwana Rukasha, Ivy Leeme, Tshepo B. Govender, Nelesh P. Ngidi, Julia Mine, Madisa Molloy, Síle F. Harrison, Thomas S. Lortholary, Olivier Jarvis, Joseph N. Diagnostic Accuracy of the Biosynex CryptoPS Cryptococcal Antigen Semiquantitative Lateral Flow Assay in Patients with Advanced HIV Disease |
title | Diagnostic Accuracy of the Biosynex CryptoPS Cryptococcal Antigen Semiquantitative Lateral Flow Assay in Patients with Advanced HIV Disease |
title_full | Diagnostic Accuracy of the Biosynex CryptoPS Cryptococcal Antigen Semiquantitative Lateral Flow Assay in Patients with Advanced HIV Disease |
title_fullStr | Diagnostic Accuracy of the Biosynex CryptoPS Cryptococcal Antigen Semiquantitative Lateral Flow Assay in Patients with Advanced HIV Disease |
title_full_unstemmed | Diagnostic Accuracy of the Biosynex CryptoPS Cryptococcal Antigen Semiquantitative Lateral Flow Assay in Patients with Advanced HIV Disease |
title_short | Diagnostic Accuracy of the Biosynex CryptoPS Cryptococcal Antigen Semiquantitative Lateral Flow Assay in Patients with Advanced HIV Disease |
title_sort | diagnostic accuracy of the biosynex cryptops cryptococcal antigen semiquantitative lateral flow assay in patients with advanced hiv disease |
topic | Mycology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7771453/ https://www.ncbi.nlm.nih.gov/pubmed/33087436 http://dx.doi.org/10.1128/JCM.02307-20 |
work_keys_str_mv | AT tenfordemarkw diagnosticaccuracyofthebiosynexcryptopscryptococcalantigensemiquantitativelateralflowassayinpatientswithadvancedhivdisease AT boyerchammardtimothee diagnosticaccuracyofthebiosynexcryptopscryptococcalantigensemiquantitativelateralflowassayinpatientswithadvancedhivdisease AT muthogacharles diagnosticaccuracyofthebiosynexcryptopscryptococcalantigensemiquantitativelateralflowassayinpatientswithadvancedhivdisease AT taweleabaneng diagnosticaccuracyofthebiosynexcryptopscryptococcalantigensemiquantitativelateralflowassayinpatientswithadvancedhivdisease AT miltonthandi diagnosticaccuracyofthebiosynexcryptopscryptococcalantigensemiquantitativelateralflowassayinpatientswithadvancedhivdisease AT rulaganyangikanyeng diagnosticaccuracyofthebiosynexcryptopscryptococcalantigensemiquantitativelateralflowassayinpatientswithadvancedhivdisease AT lechiilekwana diagnosticaccuracyofthebiosynexcryptopscryptococcalantigensemiquantitativelateralflowassayinpatientswithadvancedhivdisease AT rukashaivy diagnosticaccuracyofthebiosynexcryptopscryptococcalantigensemiquantitativelateralflowassayinpatientswithadvancedhivdisease AT leemetshepob diagnosticaccuracyofthebiosynexcryptopscryptococcalantigensemiquantitativelateralflowassayinpatientswithadvancedhivdisease AT govenderneleshp diagnosticaccuracyofthebiosynexcryptopscryptococcalantigensemiquantitativelateralflowassayinpatientswithadvancedhivdisease AT ngidijulia diagnosticaccuracyofthebiosynexcryptopscryptococcalantigensemiquantitativelateralflowassayinpatientswithadvancedhivdisease AT minemadisa diagnosticaccuracyofthebiosynexcryptopscryptococcalantigensemiquantitativelateralflowassayinpatientswithadvancedhivdisease AT molloysilef diagnosticaccuracyofthebiosynexcryptopscryptococcalantigensemiquantitativelateralflowassayinpatientswithadvancedhivdisease AT harrisonthomass diagnosticaccuracyofthebiosynexcryptopscryptococcalantigensemiquantitativelateralflowassayinpatientswithadvancedhivdisease AT lortholaryolivier diagnosticaccuracyofthebiosynexcryptopscryptococcalantigensemiquantitativelateralflowassayinpatientswithadvancedhivdisease AT jarvisjosephn diagnosticaccuracyofthebiosynexcryptopscryptococcalantigensemiquantitativelateralflowassayinpatientswithadvancedhivdisease |